Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06519669
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-19
Brief Title:
Autologous Tumor-Infiltrating Lymphocyte InjectionGT201 for Treatment of Patients With Advanced Lung Cancer
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Single-arm Clinical Study of Autologous Tumor-Infiltrating Lymphocyte GT201 Injection for Treatment of Patients With Advanced Lung Cancer
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a single arm open design aimed at evaluating the safety and tolerability of Autologous Tumor-Infiltrating Lymphocyte GT201 injection for treatment of patients with Advanced lung cancerwhile evaluating pharmacokinetic characteristics and efficacy assessment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None